Connection

L. W. Church to Viral Proteins

Back to Details
This is a "connection" page, showing publications L. W. Church has written about Viral Proteins.
L. W. Church
Connection Strength
0.035
Viral Proteins
  1. Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. J Infect Dis. 1998 Jun; 177(6):1664-73.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.